New scan could sharpen detection of aggressive breast cancer
NCT ID NCT01093612
First seen Nov 16, 2025 · Last updated May 12, 2026 · Updated 20 times
Summary
This study tests a special PET scan that uses a radioactive tracer to find HER2-positive breast cancer tumors in women with advanced (stage IV) disease. The goal is to see if this scan can better identify which tumors have the HER2 protein, helping doctors plan more targeted treatment. The trial involved 18 women and compared scan results between HER2-positive and HER2-negative tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.